Welcome Guest | Register / Login

Joint Replacement Market Research Reports

Sort By
Title Published Price
FDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent VTE in Joint Replacement Surgeries in the US
By GlobalData
Report SummaryGlobalData’s report “FDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent VTE in Joint Replacement Surgeries in the US“ provide key insight of the Joint R...
Jul 2011 $ 500